Last week, the federal government announced the members of the Committee of Experts who will oversee the national pharmacare program – and the news is good.   Thanks to our collective efforts, the committee will be free of corporate interference—a crucial step toward ensuring a program focused on people’s health over private profits, and another … Continue reading Key pharmacare committee slips out of the clutches of Big Pharma